Expression of exogenous tissue factor pathway inhibitor in vivo suppresses thrombus formation in injured rabbit carotid arteries
- 18 August 2001
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 38 (2) , 569-576
- https://doi.org/10.1016/s0735-1097(01)01350-x
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Cardiovascular gene therapyThe Lancet, 2000
- Antithrombotic Effects of Recombinant Human, Active Site–Blocked Factor VIIa in a Rabbit Model of Recurrent Arterial ThrombosisCirculation Research, 1998
- Tissue Factor Modulates the Thrombogenicity of Human Atherosclerotic PlaquesCirculation, 1997
- Enhanced In Vivo Antithrombotic Effects of Endothelial Cells Expressing Recombinant Plasminogen Activators Transduced With Retroviral VectorsCirculation, 1996
- Prevention of Arterial Thrombosis by Adenovirus-Mediated Transfer of Cyclooxygenase GeneCirculation, 1996
- A monoclonal antibody against rabbit tissue factor inhibits thrombus formation in stenotic injured rabbit carotid arteries.Circulation Research, 1994
- Prevention of arterial reocclusion after thrombolysis with recombinant lipoprotein-associated coagulation inhibitor.Circulation, 1991
- Implantation of Vascular Grafts Lined with Genetically Modified Endothelial CellsScience, 1989
- Recombinant Gene Expression in Vivo Within Endothelial Cells of the Arterial WallScience, 1989
- Platelet aggregation in partially obstructed vessels and its elimination with aspirin.Circulation, 1976